In page navigation
- 1. How to buy AstraZeneca (AZN) stock
- 2. Where to buy AstraZeneca stock?
- 3. How to buy stock in AstraZeneca in 3 simple steps
- 4. Compare the best platforms to buy AstraZeneca stock
- 5. Fundamental analysis of AstraZeneca shares
- 6. Is AstraZeneca a good investment for me?
- 7. How to sell AstraZeneca stock
- 8. Should I buy AstraZeneca stock now?
- 9. FAQs
How to buy AstraZeneca (AZN) stock
Invezz is an independent platform with the goal of helping users achieve financial freedom. In order to fund our work, we partner with advertisers who may pay to be displayed in certain positions on certain pages, or may compensate us for referring users to their services. While our reviews and assessments of each product are independent and unbiased, the order in which brands are presented and the placement of offers may be impacted and some of the links on this page may be affiliate links from which we earn a commission. The order in which products and services appear on Invezz does not represent an endorsement from us, and please be aware that there may be other platforms available to you than the products and services that appear on our website. Read more about how we make money >
Trade your favourite markets with our top-rated broker, .
10/1077% of retail CFD accounts lose money.
A big part of learning how to buy AstraZeneca stocks is finding the best place to make your investment. AstraZeneca stocks are available to invest in through an online stock broker, and it usually takes just a few minutes to buy shares in AstraZeneca when following our step by step guide.
Where to buy AstraZeneca stock?
Copy link to sectionThe best stock trading platform to use to buy AstraZeneca stock is eToro .
Based on our research, we’ve ranked the top three brokers where you can buy AstraZeneca shares, according to how easy they are to use, how low their fees are, their safety and security rating, and average customer reviews.
77% of retail CFD accounts lose money.
Buy or sell stock CFDs with Plus500. 82% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money.
Read more about how we test, rank & review platforms.
How to buy stock in AstraZeneca in 3 simple steps
Copy link to sectionBuying AstraZeneca stock is quick and easy, all you need is an internet connection and a copy of your photo ID. Here’s how to do it.
Step 1. Sign up to eToro
Copy link to sectioneToro is the best stock trading platform for beginners. Fill in your details to set up a brokerage account and attach a copy of your ID to verify it.
77% of retail CFD accounts lose money.
Step 2. Make a deposit
Copy link to sectionTransfer money to your new account with your credit or debit card, a bank transfer, or an alternative payment method, like PayPal. The minimum deposit is £10.
Step 3. Buy AstraZeneca shares
Copy link to sectionSearch for AstraZeneca using the ticker, AZN. Click the ‘trade’ button and enter the details of your investment, such as how many shares you want to buy or how much you want to spend. Hit ‘trade now’ to invest in AstraZeneca and complete your purchase.
It’s as easy as that! You can buy AstraZeneca shares in just 10-15 minutes and now you’re a AstraZeneca shareholder.
Compare the best platforms to buy AstraZeneca stock
Copy link to section1. eToro. Best for beginners, copy-trading & demo-account
2900
No. assets
$10
Minimum deposit
Stocks
Platform type
Pros & Cons
Overview
We love eToro because you can trade more than 3,000 stocks, commission free. When you buy stocks on eToro, you’re buying the underlying asset, which means you can earn dividends. Or you can trade fractional shares, which means you can invest in even the most expensive stock from just $10.
As well as being a broker that offers lots of investor protection, eToro offers a very social trading experience. You can easily see what’s trending on the stock market every day, browse the latest analyst opinion about every one of those stocks, and copy other people’s trade suggestions from your desktop or the eToro app.
The fees: Stock and ETF trades are commission free. Stock CFDs are charged a 0.15% spread and overnight fees can apply. You can deposit money for free but you have to pay $5 per withdrawal, and there’s a minimum withdrawal of $30. A $10 per month activity fee is charged if you don’t log in for a year.
77% of retail CFD accounts lose money.
2. Plus500. Best for international CFD trading*
4300
No. assets
$100
Minimum deposit
Stocks
Platform type
Pros & Cons
Overview
We love Plus500 because it is one of the industry’s most transparent and reliable brokers. Its fees are clear and you’ll know exactly what you will be paying before you make a trade. Its technology driven platform gives access to CFDs on over 2000 stocks.
Plus500 has something for all types of stock trader, no matter what level of experience. Its zero commission and tight spreads make it a top choice for day traders and its trading academy is packed with educational content, perfect for beginners just starting.
For accurate instrument availability, visit plus500.com.
The fees: There are no commission fees on any trades with Plus500 and it makes it money through the Bid/Ask spread. Spread starts from 0.01% and varies depending on the instrument. Additional fees include overnight funding depending on trade size and guaranteed stop orders, which add a minimum of 10% to the spread. There is an inactivity charge of £10 per month for accounts not logged in for three months.
*Based on a comparison of 60+ leading brokers and trading platforms.
Buy or sell stock CFDs with Plus500. 82% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money.
Fundamental analysis of AstraZeneca shares
Copy link to sectionWhat is AstraZeneca’s total worth?
Copy link to sectionAstraZeneca’s total net worth is £164.88 billion This is its total market capitalisation, calculated by multiplying the number of shares outstanding on a stock exchange by the current share price.
How has AstraZeneca’s share price performed in recent years?
Copy link to sectionThe current AstraZeneca stock price today is £107.84, which is 7.97% below its all time high of £118.86, which it reached on 13 January 2023.
Overall, AZN is up 124.14% over the last five years. The AZN share price is down 6.95% in 2024 with a 52 week high of £118.86 and a 52 week low of £83.26.
What is AstraZeneca’s EPS?
Copy link to sectionAstraZeneca’s EPS is £0.58. EPS stands for earnings per share and is calculated by dividing AstraZeneca’s net profit by the number of shares outstanding. It gives you an idea of how valuable a company is.
What is the AstraZeneca P/E ratio?
Copy link to sectionAstraZeneca’s P/E ratio is 61.27. The P/E, or price to earnings ratio, tells you how much you would have to pay per share for $1 of AstraZeneca’s earnings.
It is calculated by dividing the share price by the earnings per share. You can use AstraZeneca’s earnings estimates to predict its future (or forward) P/E and set a target price you think the stock can reach.
What is AstraZeneca’s dividend yield?
Copy link to sectionAstraZeneca’s dividend yield is 2.23%. The dividend yield tells you how much of AstraZeneca’s share price it gives back to shareholders in dividend payments every year.
Is AstraZeneca stock a buy or sell?
Copy link to sectionThe indicator below shows you live technical ratings for AstraZeneca stock on time frames from one minute to one month.
It tracks a selection of key technical indicators on live market data, including moving averages, relative strength index (RSI), oscillators, and momentum.
This indicator should be used when you research AstraZeneca to help you decide whether to buy AstraZeneca shares. Past performance is no guarantee of future results. It is not investment advice or a recommendation from Invezz to buy this stock.
Is AstraZeneca a good investment for me?
Copy link to sectionThe right answer is different for each person, so here is some information to help you decide whether to buy stocks in AstraZeneca.
- AstraZeneca consistently develops new drug treatments. Pharmaceutical companies make most of their money from creating and patenting new drugs. They then have sole rights to sell a branded drug for a set period of time (usually 10 years). This monopoly power allows them to charge high prices and generate strong profits to reinvest in creating new drugs.
- It has a diverse portfolio of drugs and patents. Relying on one or two drugs can be risky, because when the patent runs out the company loses much of its pricing power. AstraZeneca has patented many different drugs, ensuring relatively stable revenue streams over time.
- AstraZeneca produced one of the leading COVID-19 vaccines. It was one of the first companies to release a coronavirus vaccine in the west. Though demand – and the necessity – of the vaccine has fallen off since the height of the pandemic, there are still many places in the world that require it.
- The company has a large geographic reach. AstraZeneca has a presence in 100+ countries around the world, which means it’s less susceptible to localised issues like poor economic performance.
- Shareholders benefit from regular share buybacks and dividends. AstraZeneca stock offers a dividend yield of more than 2%, while the share price value is often boosted by buybacks, when the company spends some of its cash on buying its own shares to reduce the total number in circulation – and increase the value of those remaining.
- There’s lots of competition from other pharmaceutical companies. It’s just one of many pharmaceutical companies, all of which spend billions of dollars a year on research and development. All are competing to produce the next big drug and with patent rules as they are, there’s a huge benefit to being first, and a big cost to missing out.
- Big Pharma has to deal with lots of regulation. By its nature, any company in the medical profession has to deal with government regulation. The most notable form of oversight is that every drug has to be approved before it can be sold to the public. Failure to gain approval is bad news, and can have a major negative effect on the share price, while it’s very hard to predict ahead of time.
It’s always a good idea to think about any potential risks there might be as well. Use this summary of AstraZeneca’s pros and cons before you make a final decision on whether to buy AstraZeneca stock.
Pros
Copy link to section- AstraZeneca has lots of patented drugs with high pricing power
- It’s a shareholder-friendly company that regularly engages in share buybacks and dividend payments
- It was one of the first companies to develop a COVID-19 vaccine
Cons
Copy link to sectionAre there other ways to buy shares in AstraZeneca?
Copy link to sectionYes, you can invest in AstraZeneca stock in a few different ways. One option is to buy stock in AstraZeneca directly through an investment platform as laid out above, while another popular choice is to invest in a fund.
Mutual funds provide instant diversification to your investment portfolio by investing in lots of companies at once. You can invest in a FTSE 100 index fund to get exposure to AstraZeneca, or choose a pharmaceutical ETF.
Another option is to use a social copy trading platform, like eToro . Find a trader who you like and copy their AstraZeneca trades directly to your own account.
This can be a good investment strategy for beginners and a way to learn how to buy AstraZeneca shares from someone with more experience.
What are the fees for investing in AstraZeneca stock?
Copy link to sectionIt depends on the stock broker. Some platforms charge a flat fee per trade, others charge a commission as a percentage of the total trade value each time you buy AstraZeneca stocks.
Consider that there may be other costs to trading too. Other fees can include deposit and withdrawal fees, or inactivity fees if you don’t use your account for three months or more.
These are the trading platforms that charge the lowest fees for buying stocks in AstraZeneca.
| Trading platform | Trading fees |
|---|---|
| eToro | $0 |
| Skilling | $0 |
| Capital.com | $0 |
| Degiro | $0 (US) / £1.75 (UK) |
| AvaTrade | 0.13% commission |
How to sell AstraZeneca stock
Copy link to sectionWhen you decide the time is right to sell and lock in some profit (or cut your losses), log into your broker account and navigate to your portfolio.
From there, find your AstraZeneca stock and you’ll see a ‘sell’ option next to it. Click that to set the details of the trade (you don’t have to sell all your stocks at once) and sell back to cash.
Should I buy AstraZeneca stock now?
Copy link to sectionIt’s your investing goals and style that define whether now is a good time to buy. The current AstraZeneca stock price plays into it but ultimately it depends on your investment horizons.
- If you’re a short term trader: the goal is to make money by buying and selling stocks regularly to secure a profit or avoid a loss. That can mean trading hourly, daily, or weekly but the focus is always on the near future. Traders learn how to buy stocks in AstraZeneca based on short term technical analysis and don’t hold shares for a long time, so any time can be a good time to buy AZN.
- If you’re a long term investor: you’re more interested in long term price appreciation than whether a stock is up or down on any given day. The important thing is finding a stock with a strong foundation where you think the share price will be up over a period of months or years. If you think AstraZeneca’s fundamentals are solid then the best time to invest in AstraZeneca stock is after a dip or a pullback in price.
Most new traders sit somewhere between these two positions. You don’t want to actively trade AstraZeneca stock all hours of the day but you don’t want to wait years for a return either.
Either way, following AZN price news and analysis will help you decide when to dip your toe into the market.
FTSE 100 analysis ahead of Beazley, Flutter, Persimmon, AstraZeneca earnings
AstraZeneca reveals a $1.0 billion deal with Pfizer
AstraZeneca share price: death cross nears ahead of earnings
FAQs
Copy link to sectionMore stocks to buy
Invezz is a place where people can find reliable, unbiased information about finance, trading, and investing – but we do not offer financial advice and users should always carry out their own research. The assets covered on this website, including stocks, cryptocurrencies, and commodities can be highly volatile and new investors often lose money. Success in the financial markets is not guaranteed, and users should never invest more than they can afford to lose. You should consider your own personal circumstances and take the time to explore all your options before making any investment. Read our risk disclaimer >